SLC1A5 and colorectal carcinoma: Finally, although our study suggests that targeting the LINC01134/SLC1A5 axis could be a therapeutic strategy for CRC, preclinical and clinical studies are required to assess the safety and efficacy of potential therapeutic interventions.